Anti-EGFR humanized monoclonal antibody (unspecified)

· Shanghai Henlius Biotech

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-EGFR humanized monoclonal antibody (unspecified), covering 2023-04-12 to 2023-04-12. Get the full timeline:

Most recent: Clinical Trial Update: The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors. [Phase 1, Phase 2]

See pricing